Cargando…

The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction

BACKGROUND: Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least 3 months. This study attempted to provide an overview of the levels of matrix metalloproteinase-9 (MMP-9), soluble suppression tumorigenicity 2 (sST2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Artha, I. Made Junior Rina, Bakta, I. Made, Manuaba, Ida Bagus Putra, Wita, I. Wayan, Rohman, Mohammad Saifur, Astawa, I. Nyoman Mantik, Bhargah, Agha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990544/
https://www.ncbi.nlm.nih.gov/pubmed/36896223
http://dx.doi.org/10.14740/cr1455
_version_ 1784901955235086336
author Artha, I. Made Junior Rina
Bakta, I. Made
Manuaba, Ida Bagus Putra
Wita, I. Wayan
Rohman, Mohammad Saifur
Astawa, I. Nyoman Mantik
Bhargah, Agha
author_facet Artha, I. Made Junior Rina
Bakta, I. Made
Manuaba, Ida Bagus Putra
Wita, I. Wayan
Rohman, Mohammad Saifur
Astawa, I. Nyoman Mantik
Bhargah, Agha
author_sort Artha, I. Made Junior Rina
collection PubMed
description BACKGROUND: Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least 3 months. This study attempted to provide an overview of the levels of matrix metalloproteinase-9 (MMP-9), soluble suppression tumorigenicity 2 (sST2), and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) as remodeling, inflammatory, and atherosclerotic markers, as well as changes in the angina severity in patients with CTO who underwent percutaneous coronary intervention (PCI) compared to those without PCI. METHODS: This study is a preliminary report with quasi-experimental design study with a pre-test and post-test approach to compare PCI’s effect in CTO patients towards changes in MMP-9, sST2, NT-pro-BNP levels, and changes in the angina severity. Twenty subjects underwent PCI and 20 subjects with optimal medical therapy, who were then assessed at baseline and 8 weeks after intervention. RESULTS: The results of this preliminary report showed that decreased MMP-9 (pre-test: 12.07 ± 1.27 ng/mL vs. post-test: 9.91 ± 5.19 ng/mL, P = 0.049), sST2 (pre-test: 37.65 ± 20.00 ng/mL vs. post-test: 29.74 ± 15.17 ng/mL, P = 0.026) and NT-pro-BNP (pre-test: 0.63 ± 0.23 ng/mL vs. post-test: 0.24 ± 0.10 ng/mL, P < 0.001) levels were found after 8 weeks of PCI compared to those without such intervention. The levels of NT-pro-BNP were lower in the PCI group (0.24 ± 0.10 ng/mL) than in the non-PCI group (0.56 ± 0.23 ng/mL; P < 0.001). Moreover, there was an improvement of angina severity in PCI group than without PCI (P < 0.039). CONCLUSIONS: Although this preliminary report found a significant decrease in MMP-9, NT-pro-BNP, and sST2 levels in CTO patients who had undergone PCI compared to those without PCI, as well as improved angina severity in these patients, this study still has limitations. The number of samples was so small that similar studies with larger sample sizes or multicenter investigations are required to deliver more trustworthy and useful results. Nevertheless, we encourage this study as a preliminary baseline for further studies in the future.
format Online
Article
Text
id pubmed-9990544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-99905442023-03-08 The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction Artha, I. Made Junior Rina Bakta, I. Made Manuaba, Ida Bagus Putra Wita, I. Wayan Rohman, Mohammad Saifur Astawa, I. Nyoman Mantik Bhargah, Agha Cardiol Res Short Communication BACKGROUND: Chronic total occlusion (CTO) is an angiographic picture of total occlusion without blood flow which is estimated to have lasted at least 3 months. This study attempted to provide an overview of the levels of matrix metalloproteinase-9 (MMP-9), soluble suppression tumorigenicity 2 (sST2), and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) as remodeling, inflammatory, and atherosclerotic markers, as well as changes in the angina severity in patients with CTO who underwent percutaneous coronary intervention (PCI) compared to those without PCI. METHODS: This study is a preliminary report with quasi-experimental design study with a pre-test and post-test approach to compare PCI’s effect in CTO patients towards changes in MMP-9, sST2, NT-pro-BNP levels, and changes in the angina severity. Twenty subjects underwent PCI and 20 subjects with optimal medical therapy, who were then assessed at baseline and 8 weeks after intervention. RESULTS: The results of this preliminary report showed that decreased MMP-9 (pre-test: 12.07 ± 1.27 ng/mL vs. post-test: 9.91 ± 5.19 ng/mL, P = 0.049), sST2 (pre-test: 37.65 ± 20.00 ng/mL vs. post-test: 29.74 ± 15.17 ng/mL, P = 0.026) and NT-pro-BNP (pre-test: 0.63 ± 0.23 ng/mL vs. post-test: 0.24 ± 0.10 ng/mL, P < 0.001) levels were found after 8 weeks of PCI compared to those without such intervention. The levels of NT-pro-BNP were lower in the PCI group (0.24 ± 0.10 ng/mL) than in the non-PCI group (0.56 ± 0.23 ng/mL; P < 0.001). Moreover, there was an improvement of angina severity in PCI group than without PCI (P < 0.039). CONCLUSIONS: Although this preliminary report found a significant decrease in MMP-9, NT-pro-BNP, and sST2 levels in CTO patients who had undergone PCI compared to those without PCI, as well as improved angina severity in these patients, this study still has limitations. The number of samples was so small that similar studies with larger sample sizes or multicenter investigations are required to deliver more trustworthy and useful results. Nevertheless, we encourage this study as a preliminary baseline for further studies in the future. Elmer Press 2023-02 2023-02-25 /pmc/articles/PMC9990544/ /pubmed/36896223 http://dx.doi.org/10.14740/cr1455 Text en Copyright 2023, Artha et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Artha, I. Made Junior Rina
Bakta, I. Made
Manuaba, Ida Bagus Putra
Wita, I. Wayan
Rohman, Mohammad Saifur
Astawa, I. Nyoman Mantik
Bhargah, Agha
The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
title The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
title_full The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
title_fullStr The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
title_full_unstemmed The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
title_short The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction
title_sort effects of percutaneous coronary intervention on biomarkers and quality of life in patients with chronic total coronary artery obstruction
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990544/
https://www.ncbi.nlm.nih.gov/pubmed/36896223
http://dx.doi.org/10.14740/cr1455
work_keys_str_mv AT arthaimadejuniorrina theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT baktaimade theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT manuabaidabagusputra theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT witaiwayan theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT rohmanmohammadsaifur theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT astawainyomanmantik theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT bhargahagha theeffectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT arthaimadejuniorrina effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT baktaimade effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT manuabaidabagusputra effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT witaiwayan effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT rohmanmohammadsaifur effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT astawainyomanmantik effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction
AT bhargahagha effectsofpercutaneouscoronaryinterventiononbiomarkersandqualityoflifeinpatientswithchronictotalcoronaryarteryobstruction